• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性震颤患者报告的治疗满意度:满意度水平及满意度预测因素

Patient-reported treatment satisfaction in essential tremor: levels of satisfaction and predictors of satisfaction.

作者信息

Varghese Anjali, Berry Diane S, Ghanem Ali, Hernandez Nora C, Louis Elan D

机构信息

Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

出版信息

Ther Adv Neurol Disord. 2024 Oct 7;17:17562864241271994. doi: 10.1177/17562864241271994. eCollection 2024.

DOI:10.1177/17562864241271994
PMID:39380787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459580/
Abstract

BACKGROUND

Although managing symptoms is paramount for both essential tremor (ET) patients and their healthcare providers, studies of treatment satisfaction are surprisingly lacking.

OBJECTIVES

We evaluated the satisfaction of patients who used a range of treatments and assessed the relation of a wide array of factors to satisfaction.

METHODS

One hundred four ET participants (age = 74.5 ± 10.2 years) completed a battery of self-report items. These included demographic information, measures of tremor and clinical history, psychological state, current ET treatment, and a series of questions about satisfaction with treatment.

RESULTS

Analyses of responses to the four current treatment satisfaction questions revealed that the proportion of participants who were satisfied ranged from 35.0% to 57.3% (i.e., approximately 1/3 to 1/2); conversely, the proportion who were dissatisfied ranged from 9.2% to 37.0%. The remainder were neutral. Higher satisfaction levels were observed in participants who were included in treatment selection and who had undergone deep brain stimulation surgery, 's < 0.05. Lower levels of satisfaction were found in participants with a negative psychological state, higher self-rated tremor severity, head/voice/jaw tremors, and more severe physical side effects; and who used botulinum toxin therapy, 's < 0.05.

CONCLUSION

Between 1/3 and 1/2 of patients were satisfied with their treatment, whereas up to 1/3 were dissatisfied. In this initial exploration of correlates of treatment satisfaction in ET patients, we identified a number of associations between satisfaction and clinical, psychological and treatment variables. Additional research is warranted to further explore the nature of these relations over time.

摘要

背景

尽管对特发性震颤(ET)患者及其医护人员来说,控制症状至关重要,但令人惊讶的是,关于治疗满意度的研究却很缺乏。

目的

我们评估了使用一系列治疗方法的患者的满意度,并评估了一系列因素与满意度之间的关系。

方法

104名ET参与者(年龄 = 74.5 ± 10.2岁)完成了一系列自我报告项目。这些项目包括人口统计学信息、震颤测量和临床病史、心理状态、当前的ET治疗方法,以及一系列关于治疗满意度的问题。

结果

对四个当前治疗满意度问题的回答分析显示,满意的参与者比例在35.0%至57.3%之间(即大约三分之一到二分之一);相反,不满意的比例在9.2%至37.0%之间。其余为中立态度。参与治疗选择的参与者以及接受过脑深部电刺激手术的参与者满意度较高,P < 0.05。心理状态消极、自我评定的震颤严重程度较高、头部/声音/下颌震颤以及身体副作用更严重的参与者满意度较低;以及使用肉毒杆菌毒素疗法的参与者满意度较低,P < 0.05。

结论

三分之一到二分之一的患者对其治疗感到满意,而多达三分之一的患者不满意。在对ET患者治疗满意度相关因素的初步探索中,我们确定了满意度与临床、心理和治疗变量之间的一些关联。有必要进行更多研究以随着时间进一步探索这些关系的本质。

相似文献

1
Patient-reported treatment satisfaction in essential tremor: levels of satisfaction and predictors of satisfaction.原发性震颤患者报告的治疗满意度:满意度水平及满意度预测因素
Ther Adv Neurol Disord. 2024 Oct 7;17:17562864241271994. doi: 10.1177/17562864241271994. eCollection 2024.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.成人躯体形式障碍和医学无法解释的身体症状(MUPS)的非药物干预措施。
Cochrane Database Syst Rev. 2014 Nov 1;2014(11):CD011142. doi: 10.1002/14651858.CD011142.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.用于男性膀胱出口梗阻诊断和管理的尿动力学检查:UPSTREAM非劣效性随机对照试验的长期随访
Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675.
7
Botulinum toxin type B for cervical dystonia.用于治疗颈部肌张力障碍的B型肉毒毒素
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004315. doi: 10.1002/14651858.CD004315.pub2.
8
Can Surgeons or Patients Predict the Likelihood of Improvement With Nonoperative Treatment of Chronic Tennis Elbow?外科医生或患者能否预测慢性网球肘非手术治疗的改善可能性?
Clin Orthop Relat Res. 2025 Feb 27;483(8):1489-1498. doi: 10.1097/CORR.0000000000003425.
9
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
10
Interventions for eye movement disorders due to acquired brain injury.针对后天性脑损伤所致眼球运动障碍的干预措施。
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2.

引用本文的文献

1
Botulinum Toxin for the Treatment of Tremors.肉毒杆菌毒素用于治疗震颤。
Toxins (Basel). 2025 Aug 11;17(8):401. doi: 10.3390/toxins17080401.

本文引用的文献

1
WHIGET and TETRAS Ratings of Action Tremor in Patients with Essential Tremor: Substantial Association and Agreement.原发性震颤患者动作性震颤的 WHIGET 和 TETRAS 评分:高度关联和一致性。
Tremor Other Hyperkinet Mov (N Y). 2024 Mar 27;14:14. doi: 10.5334/tohm.874. eCollection 2024.
2
Trial of Botulinum Toxin for Isolated or Essential Head Tremor.肉毒杆菌毒素治疗孤立性或原发性头部震颤的试验。
N Engl J Med. 2023 Nov 9;389(19):1753-1765. doi: 10.1056/NEJMoa2304192.
3
Stigma and Social Avoidance in Adults with Essential Tremor.特发性震颤成人患者的耻辱感与社会回避行为
Mov Disord Clin Pract. 2023 Jun 21;10(9):1317-1323. doi: 10.1002/mdc3.13774. eCollection 2023 Sep.
4
Patient satisfaction following unilateral MR-guided focused ultrasound for tremor: Who is satisfied and who is not?单侧磁共振引导聚焦超声治疗震颤后的患者满意度:谁满意,谁不满意?
Parkinsonism Relat Disord. 2023 Jul;112:105439. doi: 10.1016/j.parkreldis.2023.105439. Epub 2023 May 22.
5
Prospective, longitudinal analysis of medication use in a cohort of elderly essential tremor cases.前瞻性、纵向分析老年特发性震颤病例队列中的药物使用情况。
J Neurol Sci. 2022 Nov 15;442:120387. doi: 10.1016/j.jns.2022.120387. Epub 2022 Aug 24.
6
The Pharmacotherapeutic Landscape for Essential Tremor: Quantifying the Level of Unmet Need From a Patient and Epidemiologic Perspective.特发性震颤的药物治疗全景:从患者和流行病学角度量化未满足的需求程度。
Clin Neuropharmacol. 2022;45(4):99-104. doi: 10.1097/WNF.0000000000000509. Epub 2022 Jun 11.
7
Botulinum Toxin for Essential Tremor and Hands Tremor in the Neurological Diseases: A Meta-Analysis of Randomized Controlled Trials.肉毒毒素治疗神经疾病中的特发性震颤和手部震颤:一项随机对照试验的荟萃分析。
Toxins (Basel). 2022 Mar 10;14(3):203. doi: 10.3390/toxins14030203.
8
How Common is Essential Tremor? Update on the Worldwide Prevalence of Essential Tremor.特发性震颤有多常见?特发性震颤全球患病率的最新更新。
Tremor Other Hyperkinet Mov (N Y). 2021 Jul 9;11:28. doi: 10.5334/tohm.632. eCollection 2021.
9
Fostering Well-Being in the Elderly: Translating Theories on Positive Aging to Practical Approaches.促进老年人的幸福:将积极老龄化理论转化为实用方法。
Front Med (Lausanne). 2021 Apr 9;8:517226. doi: 10.3389/fmed.2021.517226. eCollection 2021.
10
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.治疗原发性震颤的当前和未来神经药理学选择。
Curr Neuropharmacol. 2020;18(6):518-537. doi: 10.2174/1570159X18666200124145743.